单位：[1]Beijing Institute of Basic Medical Sciences, 100850 Beijing, China[2]Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA[3]School of Pharmaceutical Sciences, Wenzhou Medical University, 325035 Wenzhou, Zhejiang, China[4]Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Zhejiang Provincial People’s Hospital, 310014 Hangzhou, Zhejiang, China[5]Department of Gynecology, Zhejiang Provincial People’s Hospital, 310014 Hangzhou, Zhejiang, China[6]Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China[7]Wuhan Kingwise Biotechnology Co., Ltd., 430206 Wuhan, Hubei, China[8]Cancer Biology Research Center (Key Laboratory of the Ministry of Education),Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,430030 Wuhan,Hubei,China肿瘤生物医学中心华中科技大学同济医学院附属同济医院[9]Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 510120 Guangzhou, Guangdong, China中山大学附属第二医院[10]Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for Reproductive Health Research, 310006 Hangzhou, Zhejiang, China[11]Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, 310006 Hangzhou, Zhejiang, China[12]Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA[13]Department of Dermatology, University of California San Diego, San Diego, CA 92122, USA[14]Key Laboratory of Saline-alkali Vegetation Ecology Restoration, Ministry of Education, College of Life Science, Northeast Forestry University, 150040 Harbin, China[15]Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 250012 Jinan, Shandong, China[16]Department of Obstetrics and Gynecology, the First Affiliated Hospital, Sun Yat-Sen University, 510080 Guangzhou, Guangdong, China中山大学附属第一医院[17]Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, 200090 Shanghai, China[18]Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021 Beijing, China[19]Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China[20]Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, 310006 Hangzhou, Zhejiang, China浙江大学医学院附属妇产科医院[21]Key Laboratory of Arrhythmias of the Ministry of Education of China, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, 200120 Shanghai, China[22]Department of Biochemistry and Molecular Biology, Tongji University School of Medicine, 200120 Shanghai, China[23]The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, 324000 Quzhou, Zhejiang, China[24]Medical Research Center, and Key Laboratory of Interventional Pulmonology of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China
The retrospective review of PARP inhibitor-treated cohort in this work is supported by
funds from the National Key Technology Research and Development Program of
China (2022YFC2704200 and 2022YFC2704205), key research and development
program of Zhejiang province (2019C03010), the National Natural Science Foundation
of China (82072889, 81772787), and key project of CSCO pilot oncology research
funding (Y-2019AZZD-0359).
第一作者单位：[1]Beijing Institute of Basic Medical Sciences, 100850 Beijing, China[2]Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA
共同第一作者：
通讯作者：
通讯机构：[10]Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for Reproductive Health Research, 310006 Hangzhou, Zhejiang, China[20]Department of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang University, 310006 Hangzhou, Zhejiang, China[21]Key Laboratory of Arrhythmias of the Ministry of Education of China, Research Center for Translational Medicine, East Hospital, Tongji University School of Medicine, 200120 Shanghai, China[22]Department of Biochemistry and Molecular Biology, Tongji University School of Medicine, 200120 Shanghai, China[23]The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, 324000 Quzhou, Zhejiang, China[24]Medical Research Center, and Key Laboratory of Interventional Pulmonology of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China
推荐引用方式(GB/T 7714)：
Zhang Chao,Guo Qiang,Chen Lifeng,et al.A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors[J].SIGNAL TRANSDUCTION AND TARGETED THERAPY.2023,8(1):183.doi:10.1038/s41392-023-01401-y.
APA：
Zhang Chao,Guo Qiang,Chen Lifeng,Wu Zheming,Yan Xiao-Jian...&Zhang Jin-San.(2023).A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors.SIGNAL TRANSDUCTION AND TARGETED THERAPY,8,(1)
MLA：
Zhang Chao,et al."A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors".SIGNAL TRANSDUCTION AND TARGETED THERAPY 8..1(2023):183
医学